{"id":"W2242665894","doi":"10.1200/jco.2009.27.15_suppl.8108","title":"An open label phase II trial of the Plk1 inhibitor BI 2536, in patients with sensitive relapse small cell lung cancer (SCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Progressive disease; Chemotherapy; Phases of clinical research; Gastroenterology; Oncology; Surgery; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003101264,0.0001510706,0.001508063,0.000122673,0.00007423618,0.00001002892,0.0003907218,0.0002314937,0.00002647521],"category_scores_gemma":[0.00227463,0.00007889233,0.0001489642,0.0002992872,0.0002855552,0.0001734521,0.0001975497,0.001366386,7.490719e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004066509,"about_ca_system_score_gemma":0.003448363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001621904,"about_ca_topic_score_gemma":0.0004511024,"domain_scores_codex":[0.9962115,0.0008682242,0.001797552,0.0002297189,0.0005981203,0.0002949068],"domain_scores_gemma":[0.9959019,0.0009415755,0.00164477,0.0002874454,0.0009279962,0.0002963374],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7047566,0.05307494,0.1552057,0.00006569104,0.0006246476,0.0004486777,0.001564264,0.00003536545,0.0009074052,0.00002277976,0.01089206,0.07240184],"study_design_scores_gemma":[0.4817266,0.2323818,0.280714,0.0005555942,0.0004706322,0.000009121798,0.0001898829,0.00007474868,0.0006431852,0.00004821795,0.003062352,0.0001238334],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877279,0.000160741,0.000004920064,0.008598958,0.0008640344,0.001363374,0.00001638494,0.000003405855,0.001260224],"genre_scores_gemma":[0.9956638,0.000321207,0.0007236024,0.001984388,0.001026452,0.000009507691,0.000001689227,0.00001447312,0.0002548375],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.22303,"threshold_uncertainty_score":0.6117249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1210836524161229,"score_gpt":0.5261446769068916,"score_spread":0.4050610244907686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}